DexCom, Inc.
DXCM
$89.53
$1.882.15%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 9.77% | -5.37% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.77% | -5.37% | |||
| Cost of Revenue | 8.33% | -5.42% | |||
| Gross Profit | 10.62% | -5.35% | |||
| SG&A Expenses | 2.57% | 8.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.71% | 0.00% | |||
| Operating Income | 24.68% | -20.96% | |||
| Income Before Tax | 17.81% | -20.90% | |||
| Income Tax Expenses | -2.29% | -4.63% | |||
| Earnings from Continuing Operations | 24.86% | -25.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 24.86% | -25.36% | |||
| EBIT | 24.68% | -20.96% | |||
| EBITDA | 19.88% | -16.95% | |||
| EPS Basic | 25.83% | -25.06% | |||
| Normalized Basic EPS | 18.70% | -20.57% | |||
| EPS Diluted | 25.84% | -24.43% | |||
| Normalized Diluted EPS | 18.88% | -19.84% | |||
| Average Basic Shares Outstanding | -0.75% | -0.41% | |||
| Average Diluted Shares Outstanding | -0.89% | -1.33% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||